However, the maximum post-treatment PSA level remained elevated at 15.00 ng/mL, suggesting that a subset of patients exhibited biochemical persistence or early recurrence, which aligns with the 20% rate of residual tumor observed on six-month follow-up MRI scans (Table 1). This evidence concerns the gene KLK3 and neoplasm.